This track focuses on the development of novel vaccine platforms that enhance immunogenicity and safety. Researchers are invited to present their findings on cutting-edge technologies and methodologies in vaccine design.

This session will explore various strategies for modulating the immune system to improve vaccine efficacy. Topics may include the use of adjuvants, immune checkpoint inhibitors, and other immunomodulatory agents.

This track aims to elucidate the mechanisms underlying vaccine-induced immunity. Presentations will cover cellular and humoral responses, as well as long-term immunological memory.

This session will highlight advancements in immune profiling and the identification of immune biomarkers associated with vaccine responses. Researchers are encouraged to share their insights on personalized vaccination strategies.

This track will focus on the role of adjuvants in enhancing vaccine responses. Discussions will include novel adjuvant formulations and their mechanisms of action in promoting immunity.

This session will explore the intersection of immunotherapeutics and vaccines in the treatment of infectious diseases and cancer. Presenters will discuss innovative approaches that leverage both modalities for enhanced therapeutic outcomes.